Skip to main content
Neurotherapeutics logoLink to Neurotherapeutics
. 2021 Apr 26;18(3):2127. doi: 10.1007/s13311-021-01063-0

Correction to: The Use, Standardization, and Interpretation of Brain Imaging Data in Clinical Trials of Neurodegenerative Disorders

Adam J Schwarz 1,
PMCID: PMC8609086  PMID: 33904114

Correction to: Neurotherapeutics (2021) 10.1007/s13311-021-01027-4

The published version of this article contains an incorrect statement about the amyloid load methodology: “…100 on the AβL scale reflects the maximum load. This scale may thus be prone to a ceiling effect in individuals with near-maximal amyloid load…”. In fact, the amyloid load metric is a continuous variable with values that can exceed 100 and thus is not prone to a ceiling effect.

The original version has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Neurotherapeutics are provided here courtesy of Elsevier

RESOURCES